261 related articles for article (PubMed ID: 17764115)
1. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T
Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115
[TBL] [Abstract][Full Text] [Related]
2. [Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis].
Tanaka N; Aoyama T
Nihon Rinsho; 2004 Nov; 62(11):2137-44. PubMed ID: 15552900
[TBL] [Abstract][Full Text] [Related]
3. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
Sun HY; Lin CC; Tsai PJ; Tsai WJ; Lee JC; Tsao CW; Cheng PN; Wu IC; Chiu YC; Chang TT; Young KC
Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665576
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent PPARĪ± activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
Tian Y; Yang Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Lu Y; Moriya K; Koike K; Gonzalez FJ; Aoyama T
Glycoconj J; 2016 Dec; 33(6):927-936. PubMed ID: 27318478
[TBL] [Abstract][Full Text] [Related]
7. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
Koike K
J Gastroenterol; 2009; 44 Suppl 19():82-8. PubMed ID: 19148799
[TBL] [Abstract][Full Text] [Related]
8. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y
Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
11. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
12. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice.
Kato T; Miyamoto M; Date T; Yasui K; Taya C; Yonekawa H; Ohue C; Yagi S; Seki E; Hirano T; Fujimoto J; Shirai T; Wakita T
Cancer Sci; 2003 Aug; 94(8):679-85. PubMed ID: 12901792
[TBL] [Abstract][Full Text] [Related]
13. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1.
Tan Y; Li Y
Biochem Biophys Res Commun; 2015 Oct; 466(3):592-8. PubMed ID: 26392314
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.
Kwon YC; Sasaki R; Meyer K; Ray R
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794048
[TBL] [Abstract][Full Text] [Related]
15. [HCV core gene transgenic mouse as a model for viral hepatocarcinogenesis].
Koike K
Nihon Rinsho; 2001 Jul; 59(7):1265-70. PubMed ID: 11494535
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus core+1/ARF Protein Modulates the Cyclin D1/pRb Pathway and Promotes Carcinogenesis.
Moustafa S; Karakasiliotis I; Mavromara P
J Virol; 2018 May; 92(9):. PubMed ID: 29444947
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.
Tiwari I; Yoon MH; Park BJ; Jang KL
Cancer Lett; 2015 Jun; 362(1):131-8. PubMed ID: 25817725
[TBL] [Abstract][Full Text] [Related]
18. HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice.
Kawamura H; Govindarajan S; Aswad F; Machida K; Lai MM; Sung VM; Dennert G
Hepatology; 2006 Oct; 44(4):936-44. PubMed ID: 17006910
[TBL] [Abstract][Full Text] [Related]
19. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
Galli A; Ceni E; Mello T; Polvani S; Tarocchi M; Buccoliero F; Lisi F; Cioni L; Ottanelli B; Foresta V; Mastrobuoni G; Moneti G; Pieraccini G; Surrenti C; Milani S
Hepatology; 2010 Aug; 52(2):493-505. PubMed ID: 20683949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
